Cellular Biomedicine Group Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$127.00 | $130.51 | 9.84% | 11 | $318.60B |
| ABT | Abbott Laboratories | Outperform |
9
|
$106.89 | $118.92 | 18.35% | 7 | $186.15B |
| PFE | Pfizer | Outperform |
2
|
$26.27 | $32.87 | 16.10% | 6 | $147.23B |
| MDT | Medtronic | Outperform |
11
|
$80.38 | $92.47 | 18.81% | 21 | $105.54B |
| GSK | GSK | Outperform |
12
|
£16.36 | £17.30 | 19.19% | 12 | £65.34B |
| ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $15.89M |
| 542765 | Transpact Enterprises | - |
0
|
361.00 | 0.00 | -100.00% | 0 | 139.61M |